Because Britain deserves a smile. Updated automatically, every day.
Science & Health
The Surrey and Borders Partnership NHS foundation trust is recruiting participants aged 55 to 80 for an international trial of the drug Trontinemab. By targeting amyloid plaques in people who show early biomarkers but n…
2 matching stories 9 categories
Follow the best stories on Bluesky or subscribe with your favourite feed reader.
Scores out of ten are AI estimates of how uplifting a story is, not a measure of accuracy or importance. Different readers may feel differently. Headlines and summaries are AI-written; follow the source link for the original reporting.
How stories are selected
Good News 